Origin of raised maternal serum alpha-fetoprotein levels in second-trimester oligohydramnios

Concanavalin A (Con A) subtyping of alpha-fetoprotein (AFP) revealed higher concentrations of AFP non-reactive with Con A in sera of 12 pregnant women with second-trimester oligohydramnios and raised total serum AFP levels than in sera of 42 pregnant women with raised total serum AFP levels and a normal amniotic fluid volume. This suggests that in oligohydramnios the origin of excess AFP in the maternal compartment is amniotic fluid. It is proposed that oligohydramnios and the associated raised maternal serum AFP levels are caused by damage of the fetal membranes prior to 16 weeks of gestation resulting in leakage of amniotic fluid to the decidual tissue and resorption in the maternal circulation.     

Technical and theoretical considerations in the HLA typing of amniotic fluid cells for prenatal diagnosis and paternity testing

HLA typing of amniotic fluid cells has been used for the prenatal diagnosis of the HLA linked diseases congenital adrenal hyperplasia (21-OH-deficiency (21-OH-def) type) and complement C4 deficiency and it has also been used for the prenatal de termination of paternity. There are, however, technical difficulties in this test associated with the weak expression of some B locus antigens on amniotic fluid cells, and theoretical difficulties related to associations between particular HLA antigens and the 21-OH-def allele. Since certain HLA-B locus antigens are found in significantly increased frequencies among patients with 21-OH-def, there is a relatively high incidence of HLA-B homozygosity among the patients and over 40 percent of the parents of these patients share one or more HLA-B locus antigens. Results of some prenatal HLA typing tests may thus be difficult to interpret, and supplementary tests should be used whenever possible. HLA typing of amniotic cells is, however, the only available procedure for prenatal diagnosis of C4 deficiency and it is the best available procedure for prenatal determination of paternity. A modification of our original procedure allows HLA typing to be performed with increased numbers of HLA typing sera, and sera with optimum reactivity for amniotic fluid cells have now been selected for the definition of most of the more commonly expressed HLA antigens. Although amniotic fluid cells do not express DR antigens, amniotic fluid cells can be typed for the HLA-linked marker glyoxalase I (GLO) and this may be the informative for prenatal diagnosis in some cases.     

假单胞菌的氯儿茶酚1,2-双加氧酶基因的克隆和表达

 从土壤中分离得到1株降解2,4-二氯酚(2,4-DCP)能力较强的细菌菌株GT241-1,克隆了该菌株的3,5-二氯儿茶酚1,2-双加氧酶基因(dcpB),采用的克隆策略为:用Southern杂交对dcpB进行定位后,构建重组质粒,再用斑点杂交从重组质粒中筛选目的转化子.经序列测定得知dcpB亚克隆片段全长4303bp,其中dcpB基因编码区765bp.核苷酸和推测的氨基酸序列分析表明,dcpB与已在GenBank登记的相关基因有一定的差异.dcpB基因能够在大肠杆菌转化子中成功地表达有生物活性的酶.     

水杨酸甲酯废渣的初步分析

通过红外光谱和核磁共振方法分析生产水杨酸甲酯时所产生的废渣的主要在分，得出主要成分是４－羟基－１，３－苯二甲酸二甲酯的讨论。该化合物在药物合成上一定的用途。     

Solid phase extraction of methomyl and thiodicarb from environmental water with an activated carbon cartridge and their determination by HPLC

ＩｎｔｒｏｄｕｃｔｉｏｎＢｏｔｈｍｅｔｈｏｍｙｌａｎｄｔｈｉｏｄｉｃａｒｂａｒｅＮｍｅｔｈｙｌｃａｒｂｍａｔｅｐｅｓｔｉｃｉｄｅｓ.Ｍｅｔｈｏｍｙｌｉｓｅｆｆｅｃｔｉｖｅｏｎａｗｉｄｅｒａｎｇｅｏｆｉｎｓｅｃｔｓａｓａｎｏｖｉｃｉｄｅ,ｌａｒｖｉｃｉｄ...     

Conceptual understandings of the ecological engineering issues: in China and abroad

ＩｎｔｒｏｄｕｃｔｉｏｎＡｓａｎｅｗｂｒａｎｃｈｏｆｅｃｏｌｏｇｙａｎｄａｎｉｎｔｅｒｄｉｓｃｉｐｌｉｎａｒｙｆｉｅｌｄ,ｔｈｅｅｃｏｌｏｇｉｃａｌｅｎｇｉｎｅｅｒｉｎｇｗａｓｉｎｉｔｉａｌｌｙｆｏｒｍｕｌａｔｅｄｉｎｔｈｅｅａｒｌｙ1960ｓ.Ｄｕｒｉｎ...     

用MnSO4-Ce(SO4)2协同催化快速测定COD的研究

本文探讨了以MnSO4-Ce(SO4)2复合催化剂代替标准重铬酸钾法中的Ag2SO4，用密封消解法测定废水COD值的可行性，研究了复合催化剂总量、配比、消解时间、溶液酸度等因素对COD测定的影响。通过对各种废水COD值的测定表明，用MnSO4-Ce(SO4)2做催化剂，在165℃，较低酸度，密封消解15min是可行的。     

内电解组合工艺处理重度富营养化水体的初步中试试验

采用催化铁内电解-沸石床-生物活性炭组合工艺进行了处理重度富营养化水的中试试验.通过对进水与出水浊度、TP、CODMn、UV254、总铁、NH3-N、和NO2--N的监测,研究了本组合工艺对重度富营养化水体的处理性能.试验期间,水温约在10℃.初步结果表明,本组合工艺对浊度、TP、CODMn和UV254均有较好的去除作用,平均去除率达到50%以上,出水中铁含量均低于进水.由于水温过低,未观察到氨氮和亚硝酸盐氮的明显变化.     

跌水曝气——改进型填料(滤料)排水系统处理屠宰废水的设计

对屠宰厂原有的排水管道系统进行改造和革新 ,使之成为沉淀、厌氧好氧生物接触氧化与过滤的新型排水系统 ,用于屠宰废水处理 ,实现了达标排放     

Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy

The value of maternal serum pregnancy-associated plasma protein (PAPP)-A in screening for Down syndrome in early pregnancy was assessed using stored samples. Seventeen cases of Down syndrome and 66 unaffected control pregnancies were studied. The median PAPP-A level in the cases was 0.42 multiples of the expected value in controls (p <0.0001). Eleven cases (65 per cent) had levels less than half the expected value compared with only six controls (9 per cent). A commercial assay kit is now needed so that prospective screening with this marker can begin.